SanjivAnandMD

Nephrology • South Salt Lake, UT

Kidney & Pancreas Transplantation

Transplant Nephrologist

Join to view full profile

Dr. Anand is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Anand's full profile

Already have an account?

Office
3702 S State St
Ste 107
South Salt Lake, UT 84115
Phone+1 801-288-2634

Fax+1 801-288-1186

Summary

Dr. Sanjiv Anand, MD, received his medical degree from University College of Medical Sciences, India. He then obtained a master’s degree in visual neurosciences from SUNY, NY. He then completed his residency in internal medicine from Maimonides Medical Center, NY, and nephrology fellowship from Indiana University, Indianapolis.
Subsequently, Dr. Anand completed a transplant nephrology fellowship at Indiana University, Indianapolis. His special interests are resistant hypertension, glomerulonephritis, hypertension in hemodialysis, fluid and electrolyte disorders, polycystic kidney disease and kidney and pancreas transplantation. Dr. Anand speaks English, Hindi and Punjabi. Dr. Anand is board certified in internal medicine and nephrology.

Education & Training

Indiana University School of MedicineKidney and Pancreas Transplant, 2012 - 2013
Indiana University School of MedicineFellowship, Nephrology, 2010 - 2012
Maimonides Medical CenterResidency, Internal Medicine, 2007 - 2010
Delhi University College of Medical SciencesClass of 2004

Certifications & Licensure

ID State Medical License 2019 - 2026
UT State Medical License 2013 - 2026
CO State Medical License 2019 - 2025
MT State Medical License 2019 - 2025
NV State Medical License 2021 - 2025
IN State Medical License 2011 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Transplant NephrologyTransplant Nephrology

Clinical Trials

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis Start of enrollment: 2014 Jun 26
Completed
Phase 3
Study to Evaluate Vadadustat for the Correction of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease Start of enrollment: 2015 Dec 01
Completed
Phase 3
Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Start of enrollment: 2016 Feb 01
Completed
Phase 3
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome Start of enrollment: 2019 Nov 02
Terminated
Phase 2
Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) Start of enrollment: 2017 Jan 11
Completed
Phase 3
A Study of RG-012 in Subjects With Alport Syndrome Start of enrollment: 2017 Dec 22
Completed
Phase 1
The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2018 Sep 14
Completed
Phase 2
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) Start of enrollment: 2019 Nov 06
Recruiting
Trifecta-Kidney cfDNA-MMDx Study Start of enrollment: 2019 Dec 01
Recruiting
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease Start of enrollment: 2021 Sep 21
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

64 citations
Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study.
Lihong Bu, Gaurav Gupta, Akshta Pai, Sanjiv Anand, Erik Stites
Kidney International. 2022-04-01
7 citations
Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant.
Jonathan S Bromberg, Suphamai Bunnapradist, Milagros Samaniego-Picota, Sanjiv Anand, Erik Stites
Transplantation. 2024-09-01
11 citations
Longitudinal variance of Donor-Derived Cell-Free DNA (dd-cfDNA) in Stable Kidney Transplant (KTx) patients are influenced by donor/recipient variables.
Sanjiv Anand, Fidel Lopez-Verdugo, Jorge Sanchez-Garcia, Li Dong, Megan Fife
Clinical Transplantation. 2021-06-24

Journal Articles

Functional Assessment of Kidney Transplant Candidates with the 6 Minute Walk Test and Hand Grip Strength
• Anand S., Gilligan S., Morris D., Srinivas T, Am J Transplant. 2017;17.
Cardiac Function and Cardiac Biomarkers among Kidney Transplant Candidates
• Gilligan S., Anand S., Morris D., Minder M., Srinivas T, Am J Transplant. 2017;17
Daratumumab for Severe Refractory Proliferative Glomerulonephritis with Monoclonal Immune Deposits (PGNMID)
• Anand, S., Miller, D., Chipman, G., Morris, D., & Srinivas, T, AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 17, pp. 568-568)
Recurrent infection with Pseudomonas aeruginosa during eculizumab therapy in an allogeneic hematopoietic stem cell transplant recipient.
• Webb, B. J., Healy, R., Child, B., Majers, J., Anand, S., & Gouw, L, Transplant Infectious Disease, 18(2), 312-314.
Acute Intracranial Hematoma in Herpes Simplex Encephalitis: An Unusual Presentation
S. Anand, R. Crusio, R. Tarkvosky, E. Chapnick, Infectious Diseases in Clinical Practice. 18(1):67-70, January 2010.
Join now to see all

Abstracts/Posters

Kidney Allograft Outcomes in Living Donor Positive Cross Match (+XMT) Recipients Maintained on Early Steroid Withdrawal (ESW) Immunosuppression
• S. Anand, W. Goggins, T. Taber, N. Higgins, A. Lobashevsky, A. Sharfuddin, M. Yaqub, D. Mishler, M. Mujtaba, ATC 2013
Impact of Seasonal Influenza Immunization (Influenza+ H1N1) on HLA Antibodies and Kidney Allograft Function
• M. Mujtaba, M. Urabi, S. Anand, A. Sharfuddin, N. Higgins, S. Faiz, M. Yaqub, D. Mishler, A. Lobashevsky, T. Taber, ATC 2013
Association of Pancreas Auto-Antibodies (AA) with Donor Specific Anti-HLA Antibodies (DSA) and Pancreatic Allograft Function
M. Mujtaba, B. Book, T. Taber, J. Fridell, S. Anand, A. Sharfuddin, M. Yaqub, D. Mishler, E. Wiebke, M. Rigby., ATC 2013
Chronic Kidney Disease in patients with Pancreas Transplant Alone: A Kidney Biopsy Study
Muhammad A Mujtaba, Jonathan Fridell, Sanjiv Anand, Michelle Goble, M. Sohail Yaqub, Asif Sharfuddin, Dennis Mishler and Tim Taber, ATC 2012
Prospective HLA Donor Specific Antibody (DSA) Monitoring in Patient with Multivisceral/Modified Multivisceral and Isolated Small Bowel Transplantation
Muhammad Mujtaba, Tim Taber, Praveen Kandula, Sanjiv Anand,, Asif Sharfuddin, M. Sohail Yaqub, Chandershekar Kubal, Karanam Karthik, Nancy Higgins, Andrew Lobashevsky,..., ATC 2012
De Novo Donor Specific Antibodies Among Non-Desensitized Renal Transplant Patients Predicts Antibody Mediated Rejection but Does Not Predict Renal Function at 1 Year.
P. Knadula, S. Anand, M. Mujtaba, A. Sharfuddin, M Yaqub, T. Taber, ASN 2011
Bilateral Emphysematous Pyelonephritis- A Rare But Serious Disease
P. Kandula, S. Anand, ASN 2011
Bilateral renal infarction secondary to patent foramen ovale
S. Anand, K.C.Janga, S. Nasika, S. Gadde, S. Greenberg, NKF 2009
o Stent or Not to Stent is the Question.
• J. Patel, S. Anand, K. Ali, M. Freidman, ACP 2009
Receptive field arrangement of thalamic afferents within an orientation domain in cat primary visual cortex
• J. Jin, C. Weng, S. Anand, H. A. Swadlow, J. M. Alonso, Society for Neuroscience, 2007.
Kidney Allograft Outcomes in Living Donor Positive Cross Match (+XMT) Recipients Maintained on Early Steroid Withdrawal
S. Anand, W. Goggins, T. Taber, N. Higgins, A. Lobashevsky, A. Sharfuddin, M. Yaqub, D. Mishler, M. Mujtaba., ATC 2013
Join now to see all

Press Mentions

CareDx Shares Latest Clinical Data at the TTS 2020 Virtual ConferenceSeptember 11th, 2020
Check Your Health: New Treatment for Kidney Failure Patients with Rare DisorderAugust 30th, 2017
Novel Treatment Offers Kidney Failure Patients with Rare Disorder New HopeMay 3rd, 2017